0001437749-19-013873.txt : 20190711
0001437749-19-013873.hdr.sgml : 20190711
20190711200643
ACCESSION NUMBER: 0001437749-19-013873
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190709
FILED AS OF DATE: 20190711
DATE AS OF CHANGE: 20190711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mathers James
CENTRAL INDEX KEY: 0001676166
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 19951853
MAIL ADDRESS:
STREET 1: C/O BIOLIFE SOLUTIONS
STREET 2: 3303 MONTE VILLA PARKWAY, SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-07-09
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001676166
Mathers James
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL
WA
98021
1
Vice President, Global Sales
Common Stock
2019-07-09
4
M
0
2500
1.64
A
19884
D
Common Stock
2019-07-09
4
S
0
2500
17.94
D
17384
D
Common Stock
2019-07-10
4
M
0
2500
1.64
A
19884
D
Common Stock
2019-07-10
4
S
0
2500
18.08
D
17384
D
Common Stock
2019-07-11
4
M
0
2500
1.64
A
19884
D
Common Stock
2019-07-11
4
S
0
2500
17.15
D
17384
D
Employee Stock Option
1.64
2019-07-09
4
M
0
2500
0
D
2019-03-01
2021-12-20
Common Stock
2500
112113
D
Employee Stock Option
1.64
2019-07-10
4
M
0
2500
0
D
2019-03-01
2021-12-20
Common Stock
2500
109613
D
Employee Stock Option
1.64
2019-07-11
4
M
0
2500
0
D
2019-03-01
2021-12-20
Common Stock
2500
107113
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019.
/s/ James Mathers
2019-07-11